Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
-- Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT-- SHANGHAI, China and SAN FRANCISCO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or “the Company”) (NASDAQ:...
-
Study demonstrated comparable profile to non-Chinese patientsClinical study published in The Oncologist SHANGHAI, China, and SAN FRANCISCO, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited...
-
SHANGHAI, China and SAN FRANCISCO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or “the Company”) (NASDAQ: ZLAB), a China and US-based innovative commercial-stage biopharmaceutical...
-
SHANGHAI, China and SAN FRANCISCO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced...
-
SHANGHAI, China and ST. HELIER, Jersey, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, and Novocure...
-
WILMINGTON, Del. and SHANGHAI, China, July 02, 2019 (GLOBE NEWSWIRE) -- Incyte (NASDAQ:INCY) and Zai Lab Ltd. (NASDAQ:ZLAB) today announced that the companies have entered into a collaboration and...
-
SHANGHAI, China and SAN FRANCISCO, June 12, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, today announced its...
-
- Zai Lab to Lead the Development and Commercialization of Ripretinib in Greater China -- Deciphera To Receive $20 Million Upfront Cash Payment, up to $185 Million in Potential Future Milestones and...
-
SHANGHAI, China and SAN FRANCISCO, June 03, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the...
-
SHANGHAI, China, May 29, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that members of the...